Your browser doesn't support javascript.
loading
Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Kondo, Toru; Jering, Karola S; Borleffs, C Jan Willem; de Boer, Rudolf A; Claggett, Brian L; Desai, Akshay S; Dobreanu, Dan; Inzucchi, Silvio E; Hernandez, Adrian F; Janssens, Stefan P; Jhund, Pardeep S; Kosiborod, Mikhail N; Lam, Carolyn S P; Langkilde, Anna Maria; Martinez, Felipe A; Petersson, Magnus; Vinh, Pham Nguyen; Vaduganathan, Muthiah; Solomon, Scott D; McMurray, John J V.
Afiliação
  • Kondo T; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, UK (T.K., P.S.J., J.J.V.M.).
  • Jering KS; Department of Cardiology, Nagoya University Graduate School of Medicine, Japan (T.K.).
  • Borleffs CJW; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (K.S.J., B.L.C., A.S.D., M.V., S.D.S.).
  • de Boer RA; Haga Teaching Hospital, the Hague, the Netherlands (C.J.W.B.).
  • Claggett BL; Erasmus Medical Center, Rotterdam, the Netherlands (R.A.d.B.).
  • Desai AS; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (K.S.J., B.L.C., A.S.D., M.V., S.D.S.).
  • Dobreanu D; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (K.S.J., B.L.C., A.S.D., M.V., S.D.S.).
  • Inzucchi SE; University of Medicine, Pharmacy, Science and Technology "G.E. Palade," Târgu Mureș, Romania (D.D.).
  • Hernandez AF; Yale School of Medicine and Yale-New Haven Hospital, CT (S.E.I.).
  • Janssens SP; Duke University Medical Center, Durham, NC (A.F.H.).
  • Jhund PS; Cardiac Intensive Care, Department of Cardiovascular Diseases, University Hospitals Leuven, Belgium (S.P.J.).
  • Kosiborod MN; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, UK (T.K., P.S.J., J.J.V.M.).
  • Lam CSP; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, MO (M.N.K.).
  • Langkilde AM; National Heart Centre Singapore & Duke-National University of Singapore (C.S.P.L.).
  • Martinez FA; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (A.M.L., M.P.).
  • Petersson M; University of Cordoba, Argentina (F.A.M.).
  • Vinh PN; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (A.M.L., M.P.).
  • Vaduganathan M; Cardiovascular Center, Tam Anh hospital, Tan Tao University, Vietnam (P.N.V.).
  • Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (K.S.J., B.L.C., A.S.D., M.V., S.D.S.).
  • McMurray JJV; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (K.S.J., B.L.C., A.S.D., M.V., S.D.S.).
Circulation ; 147(14): 1067-1078, 2023 04 04.
Article em En | MEDLINE | ID: mdl-36876483
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article